Ras inhibition attenuates pancreatic cell death and experimental type 1 diabetes: Possible role of regulatory T cells

European Journal of Pharmacology

Volumn 643, Issue 1, 2010, Pages 139-144

  Aizman, Elizabeta ^a   Mor, Adi ^a   George, Jacob ^b   Kloog, Yoel ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b KAPLAN MEDICAL CENTER   (Israel)

Author keywords

Diabetes; F FTS; Foxp3; NOD; Ras; Regulatory T cell

Indexed keywords

5 FLUORO FARNESYLTHIOSALICYLIC ACID; ANTIDIABETIC AGENT; CASPASE 3; INSULIN; RAS PROTEIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL INFILTRATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOREGULATION; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTECTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; WESTERN BLOTTING;

EID: 77955055583     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.06.029     Document Type: Article

References (21)

1. Aharonson Z., Gana-Weisz M., Varsano T., Haklai R., Marciano D., Kloog Y. Stringent structural requirements for anti-Ras activity of S-prenyl analogues. Biochim. Biophys. Acta 1998, 1406:40-50.
2. Blum R., Jacob-Hirsch J., Rechavi G., Kloog Y. Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosis. Mol. Cancer Ther. 2006, 5:2337-2347.
3. Blum R., Cox A.D., Kloog Y. Inhibitors of chronically active Ras: potential for treatment of human malignancies. Recent Pat. Anticancer Drug Discov. 2008, 3:31-47.
4. Cox A.D., Der C.J. The Ras/cholesterol connection: implications for Ras oncogenicity. Crit. Rev. Oncog. 1992, 3.
5. de Castro I.P., Diaz R., Malumbres M., Hernandez M.I., Jagirdar J., Jimenez M., Ahn D., Pellicer A. Mice deficient for N-Ras: impaired antiviral immune response and T-cell function. Cancer Res. 2003, 63:1615-1622.
6. Der C.J., Van Dyke T. Stopping Ras in its tracks. Cell 2007, 129:855-857.
7. Eisenberg S., Henis Y.I. Interactions of Ras proteins with the plasma membrane and their roles in signaling. Cell. Signal. 2008, 20:31-39.
8. Goldberg L., Kloog Y. A Ras inhibitor tilts the balance between rac and rho and blocks PI3-kinase-dependent glioblastoma cell migration. Cancer Res. 2006, 66:11709-11717.
9. + T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc. Natl Acad. Sci. USA 2003, 100:10878-10883.
10. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J. Exp. Med. 2004, 199:1479-1489.
11. Ilarregui J.M., Croci D.O., Bianco G.A., Toscano M.A., Salatino M., Vermeulen M.E., Geffner J.R., Rabinovich G.A. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat. Immunol. 2009, 10:981-991.
12. Karusis, D., Abramsky, O., Grigoriadis, N., Chapman, J., Mizrachi-Koll, R., Niv, H., Kloog, Y., 2001. The Ras-pathway inhibitor S, trans-trans farnesythiosalicylic acid (FTS) suppresses experimental allergic encephalomyelitis. J. Neuroimmunol. 120, 1-9.
13. Katzav A., Kloog Y., Korczyn A.D., Niv H., Karussis D.M., Wang N., Rabinowitz R., Blank M., Shoenfeld Y., Chapman J. Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS). Clin. Exp. Immunol. 2001, 126:570-577.
14. Mor A., Keren G., Kloog Y., George J. N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cells. Eur. J. Immunol. 2008, 38:1493-1502.
15. Mor A., Kloog Y., Keren G., George J. Ras inhibition increases the frequency and function of regulatory T cells and attenuates type-1 diabetes in non-obese diabetic mice. Eur. J. Pharmacol. 2009, 616:301-305.
16. Philips M.R. Compartmentalized signalling of Ras. Biochem. Soc. Trans. 2005, 33:657-661.
17. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
18. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000, 12:431-440.
19. +thymocytes. Proc. Natl Acad. Sci. USA 1996, 93:4683-4687.
20. + regulatory T cells. J. Immunol. 2003, 171:3348-3352.
21. + regulatory T-cells contributes to the onset of autoimmune diabetes. Diabetes 2008, 57:113-123.